Gastrin antagonists for treatment and prevention of osteoporosis
AssigneeClifton Life Sciences LLC
InventorsIrvin Mark Modlin, Mark Kidd
Life of this patent
Estimating the term…
Loading patent…
AssigneeClifton Life Sciences LLC
InventorsIrvin Mark Modlin, Mark Kidd
Estimating the term…
The provided embodiments are based in some aspects on the demonstration herein of a role for gastrin in regulating the aging gut-ovary axis and effects of targeting gastrin activity in reversing gastrin-mediated bone loss. Provided are methods, compositions and agents, including gastrin antagonists, for treatment, amelioration, and prevention of bone diseases and conditions. Methods for treating a bone disease or condition associated with hypergastrinemia in a subject in need thereof may comprise administering to the subject at least one dose of a therapeutically effective amount of a gastrin receptor-targeting agent, thereby treating the bone disease or condition associated with hypergastrinemia.
A method for treating a bone disease or condition associated with hypergastrinemia in a subject in need thereof, comprising administering to the subject at least one dose of a therapeutically effective amount of a gastrin receptor-targeting agent, thereby treating the bone disease or condition associated with hypergastrinemia.
Dependencies are inferred from the claim text.